Library Updates

President Otto Pérez Molina: War on Drugs has Failed

July 3, 2012 Global Policy News

At the launch of the Beckley Foundation Guatemala, President Otto Pérez Molina becomes the first incumbent Head of Government to sign the Beckley Foundation Public Letter.

Continue Reading →

Effect of drug law enforcement on drug market violence: A systematic review

June 15, 2011 Drug Policy Library

Violence is amongst the primary concerns of communities around the world and research has demonstrated links between violence and the illicit drug trade, particularly in urban settings. Given the growing emphasis on evidence-based policy-making, and the ongoing severe drug market violence in Mexico and other settings, we conducted a systematic review to examine the impacts […]

Continue Reading →
Thumbnail image for Ecstasy Does Not Wreck the Mind

Ecstasy Does Not Wreck the Mind

February 21, 2011 Featured Slider

The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide.  Past research has suggested that ecstasy users perform worse than non-users on some tests of mental ability.  But there are concerns that the methods used to conduct that research were flawed, and the experiments […]

Continue Reading →
Thumbnail image for Innocent Bystanders: Developing Countries and the War on Drugs

Innocent Bystanders: Developing Countries and the War on Drugs

February 16, 2011 Drug Policy Library

Drug use/abuse is one of the most difficult challenges facing the contemporary world. If it is true that there has always been consumption of different types of drugs in different societies—although not in all of them—it is no less true that it generally took place in restricted, socially regulated realms, especially in ritualistic ceremonies. This […]

Continue Reading →
Thumbnail image for Cannabis Use and Earlier Onset of Psychosis

Cannabis Use and Earlier Onset of Psychosis

February 16, 2011 Cannabis

Cannabis is the most widely used addictive substance after tobacco and alcohol. The 2009 National Survey on Drug Use and Health reported that more than 16 million Americans use cannabis on a regular basis, most of whom started using cannabis and other drugs during their teenage years. There is little doubt about the existence of an association […]

Continue Reading →
Thumbnail image for From the Mountaintops: What The World Can Learn from Drug Policy Change in Switzerland

From the Mountaintops: What The World Can Learn from Drug Policy Change in Switzerland

February 11, 2011 Drug Policy Library

Switzerland, a country renowned for its solid conservatism, was shaken by seeing its cities become the point of convergence of thousands of drug users and counterculture activists, culminating in large open drug scenes in the late 1980s. The country was hit hard by HIV, which was strongly linked—both in the public mind and in reality—to […]

Continue Reading →

Effects of Cannabidiol on Schizophrenia-like Symptoms in People Who use Cannabis

February 11, 2011 Cannabis

Convergent evidence suggests a link between cannabis use and psychosis. However, cannabis comprises a combination of cannabinoids and these different constituents may have distinct effects, not all of which are detrimental to mental health. The main component of smoked cannabis is D9-tetrahydrocannabinol (D9-THC), which is thought to be responsible for the majority of the psychotomimetic […]

Continue Reading →

Cannabis – Recent Advances

February 11, 2011 Cannabis

Over the last 40 years, cannabinoid chemistry and pharmacology have been the object of thousands of publications. For obvious reasons, most attention has been paid to Cannabis. As cannabidiol (CBD; generally found in relatively high concentrations in Cannabis, several groups have also investigated the pharmacological activities of this component, although not to the extent that […]

Continue Reading →

Cannabis, the Mind and Society: The Hash Reality

February 11, 2011 Cannabis

The classical Greek term pharmakon indicates that a substance can be a remedy as well as a poison, and in many traditional societies cannabis was considered to have both of these properties. However, as the twentieth century progressed, cannabis gradually lost its status as a useful remedy, and fewer and fewer people regarded it as […]

Continue Reading →

Cannabidiol, A Cannabis Sativa

February 11, 2011 Cannabis

A high dose of A9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of A9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. […]

Continue Reading →

CANNABIDIOL INTERFERES WITH THE EFFECTS OF A9-TETRAHYDROCANNABINOL IN MAN

February 10, 2011 Cannabis

A9-THC) in laboratory animals, the present work was carried out to study possible interaction between CBD and A9-THC in human beings. In a double blind procedure, 40 healthy male volunteers were assigned to 1 of 8 experimental groups, receiving per oral route, placebo, 30 mg A9-THC, 15, 30 or 60 mg of CBD, and mixtures […]

Continue Reading →

Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders

February 9, 2011 Cannabis

Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa and belongs to the so-called ‘cannabinoids’ (CBs). This term refers to a heterogeneous family of molecules usually exhibiting pharmacological properties by interacting with specific receptors. So far, two membrane receptors for CBs, both coupled to G protein and named CB1 and […]

Continue Reading →

Cannabidiol For the Treatment of Psychosis in Parkinson’s Disease

February 9, 2011 Cannabis

The management of psychosis in Parkinson’s disease (PD) has been considered a great challenge for clinicians and there is a need for new pharmacological intervention. Previously an antipsychotic and neuroprotective effect of Cannabidiol (CBD) has been suggested. Therefore, the aim of the present study was to directly evaluate for the first time, the efficacy, tolerability […]

Continue Reading →

Antisychotic Effects of Cannabidiol

February 9, 2011 Cannabis

Background: In contrast to delta-9-tetrahydrocannabinol, the phytocannabinoid cannabidiol does not exert psychotomimetic effects. Cannabidiol was suggested a re-uptake inhibitor of anandamide and potential antipsychotic properties have been hypothesized for it. We therefore performed a clinical trial to investigate thesis hypothesis and to clarify the underlying link to the neurobiology of schizophrenia. Methods: We performed an […]

Continue Reading →
Thumbnail image for Drugs as Instruments – A New Framework for Non-addictive Psychoactive Drug Use

Drugs as Instruments – A New Framework for Non-addictive Psychoactive Drug Use

February 8, 2011 Featured Slider

A shortly to be published article in Behavioural and Brain Sciences by Christian  Müller and Gunter Schumann greatly supports the message that the Beckley Foundation has been trying to promote for years that there is a distinction between Drug Use and Drug Abuse, many people use drugs throughout their lives without causing  harm to themselves […]

Continue Reading →
Thumbnail image for Colombia to Rethink Drug Stance?

Colombia to Rethink Drug Stance?

February 1, 2011 Featured Slider

Two major events have occurred recently which could perhaps be viewed as indications of a governmental re-evaluation of drug policy. President Juan Manuel Santos was recently in France trying to encourage Foreign Direct Investment and grace a higher profile for his country in world affairs. Santos was asked his opinions on the illegal drug trade […]

Continue Reading →
Thumbnail image for Agony Over Ecstasy is Helping No One

Agony Over Ecstasy is Helping No One

February 1, 2011 Global Policy News

Last Friday night, Matthew Chesher, then a senior official of the NSW government and husband of a state minister, was observed by police to have allegedly purchased a tablet of ecstasy. Chesher immediately resigned. His wife issued a statement of regret while also strongly supporting her husband. This is nonsense on stilts. Scarce police resources […]

Continue Reading →
Thumbnail image for Pot Growers Team Up To Go Legit In California County

Pot Growers Team Up To Go Legit In California County

February 1, 2011 Library Updates

Joey Burger was 14 when his naturalist parents moved from Santa Cruz to settle in the coastal forest of Humboldt County. Local hippies and homesteaders welcomed the new kid in the woods.  They schooled him in the regional art – growing marijuana. “It was never looked upon as a bad thing,” Burger said. Except before […]

Continue Reading →
Thumbnail image for Experiences of Psilocybin in BF Study

Experiences of Psilocybin in BF Study

February 1, 2011 Featured Slider

Part of the Beckley Foundation/Imperial College Psychedelic Research Program In the worlds first study with psilocybin and fMRI the Beckley Foundation’s director Amanda Feilding, working with Professor David Nutt and Dr Carhart Harris, have investigated the effects of psilocybin on blood flow in the brain using fMRI to identify the functional brain correlates of the […]

Continue Reading →

Cannabis Social Clubs in Spain

January 28, 2011 Library Updates

January 2011, Source: Transnational Institute and the Federation of Cannabis Association Cannabis social clubs (CSC) are noncommercial organisations of users who get together to cultivate and distribute enough cannabis to meet their personal needs without having to turn to the black market. They are based on the fact that the consumption of illegal drugs has […]

Continue Reading →

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

January 19, 2011 Beckley Science in the Media

Authors: Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O’ Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Neuropsychopharmacology. 2010 Feb;35(3):764-74. Abstract Delta-9-tetrahydrocannabinol (Delta-9-THC) and Cannabidiol (CBD), the two main ingredients […]

Continue Reading →

Disruption of Frontal Theta Coherence by Δ(9)-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms.

January 19, 2011 Beckley Science in the Media

Authors: Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen R, Holt D, Wilson D, Sumich A, McGuire P, Murray RM, Kapur S, Ffytche DH. The Biomedical Research Centre, Institute of Psychiatry, King’s College London, Denmark Hill, UK. Neuropsychopharmacology. 2010 Dec 8 Abstract The main ingredient in cannabis, Δ(9)-tetrahydrocannabinol (THC), can elicit acute […]

Continue Reading →

The administration of psilocybin to healthy hallucinogen-experienced volunteers in a mock-fMRI environment: a preliminary investigation of tolerability

January 19, 2011 Beckley Science in the Media

Authors: Carhart-Harris RL¹², Williams TM², Sessa B², Tyacke RJ¹², Rich AS², Feilding A³, Nutt DJ¹² ¹ Imperial College London, Dept of Neuropsychopharmacology ² University of Bristol, Psychopharmacology Unit ³ The Beckley Foundation ²Corresponding author: r.carhart-harris@imperial.ac.uk Abstract: This study sought to assess the tolerability of intravenously administered psilocybin in healthy, hallucinogen-experienced volunteers in a mock-magnetic resonance […]

Continue Reading →